Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
With no downtime, you can return to your routine
Not intended to diagnose, treat, cure, or prevent any condition.
Translational Psychiatry , 15:344
Its given either by injection into a muscle or under the skin
This is especially helpful for people with inflammatory conditions, aiding in quicker recovery from illnesses and injuries
US$ 27.70
US$ 28.30
US$ 29.45
US$ 25.90
US$ 20.30
US$ 23.69
US$ 24.79
US$ 24.95
US$ 22.05
